Abstract:PURPOSE: To detect changes in brain lateralization in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) using resting-state functional magnetic resonance imaging (fMRI).MATERIALS AND METHODS: Data from 61 well-matched right-handed subjects were obtained from the Alzheimer's Disease Neuroimaging Initiative, including 19 healthy controls (HCs), 25 patients with MCI, and 17 patients with AD. First, we divided 256 pairs of seed regions from each hemisphere covering the entire cerebral gray matter. Then, we used the intrinsic laterality index (iLI) approach to quantify the functional laterality using fMRI. One-way ANOVA was employed to estimate the differences in iLI among the three groups. The sum, number and mean value of the iLI were calculated within the thresholds of 0 < |iLI| < 0.2, 0.2 ≤ |iLI| < 0.4, 0.4 ≤ |iLI| < 0.8, and |iLI| ≥ 0.8, to explore the changes in the lateralization of resting-state brain function in patients with MCI and AD.RESULTS: One-way ANOVA revealed that the iLIs of the three groups were significantly different. The HCs showed a significant leftward interhemispheric difference within |iLI| ≥ 0.8. Compared with the HCs, the patients with MCI manifested a distinct abnormal rightward interhemispheric asymmetry, mainly within the thresholds of 0.2 ≤ |iLI| < 0.4 and 0.4 ≤ |iLI| < 0.8; in the patients with AD, the normal leftward lateralization that was observed in the HCs disappeared, and an abnormal rightward laterality was expressed within 0.4 ≤ |iLI| < 0.8. By directly comparing the patients with MCI with the patients with AD, an exclusive abnormal rightward laterality was observed in the patients with MCI within the 0.2 ≤ |iLI| < 0.4 threshold, and the normal leftward asymmetry vanished in the patients with AD within the |iLI| ≥ 0.8 threshold.CONCLUSION: Global brain lateralization was different among three groups. The abnormal rightward dominance observed in the patients with MCI and AD may indicate that these patients use additional brain resources to compensate for the loss of cognitive function, and the observed disappearance of the leftward laterality in the patients with AD was likely associated with the damage in the left hemisphere. The observed disappearance of the rightward asymmetry in the patients with AD using the 0.2 ≤ |iLI| < 0.4 threshold was likely a sign of decompensation. Our study provides new insights that may improve our understanding of MCI and AD.

[P4-247]: LEFT LATERALIZED CEREBRAL GLUCOSE METABOLISM DECLINES IN AMYLOID-β-POSITIVE SUBJECTS WITH MILD COGNITIVE IMPAIRMENT

[IC‐P‐210]: LEFT LATERALIZED CEREBRAL GLUCOSE METABOLISM DECLINES IN AMYLOID‐β– POSITIVE SUBJECTS WITH MILD COGNITIVE IMPAIRMENT

Left Lateralized Cerebral Glucose Metabolism Declines in Amyloid-Β Positive Persons with Mild Cognitive Impairment.

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

IC-P2-098: Frequency of Hemispheric Metabolic Asymmetry in Probable Alzheimer's Disease

P1-244: Frequency of Hemispheric Metabolic Asymmetry in Probable Alzheimer's Disease

Decreased Bilateral FDG-PET Uptake and Inter-Hemispheric Connectivity in Multi-Domain Amnestic Mild Cognitive Impairment Patients: A Preliminary Study

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Changes in Brain Lateralization in Patients with Mild Cognitive Impairment and Alzheimer’s Disease: A Resting-State Functional Magnetic Resonance Study from Alzheimer’s Disease Neuroimaging Initiative

IC‐P1‐036: Categorical and Correlational Analyses of Baseline Fluorodeoxyglucose Positron Emission Tomography Images from the Alzheimer's Disease Neuroimaging Initiative

Distinct Laterality Alterations Distinguish Mild Cognitive Impairment and Alzheimer'S Disease from Healthy Aging: Statistical Parametric Mapping with High Resolution Mri

P4‐053: Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data from the Alzheimer'S Disease Neuroimaging Initiative Study

Categorical and Correlational Analyses of Baseline Fluorodeoxyglucose Positron Emission Tomography Images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Relationship Between Longitudinal, Structural Magnetic Resonance Imaging and [18f]fluorodeoxyglucose Positron Emission Tomography Data From The Alzheimer'S Disease Neuroimaging Initiative Study

IC-P2-086: the Pattern of Cerebral Hypometablism in Amnestic Mild Cognitive Impairment and Its Relationship to Subsequent Conversion to Probable Alzheimer's Disease: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative

Twelve-month Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Assessed Using an Empirically Pre-Defined Statistical Region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Correlating Cerebral Hypometabolism with Future Memory Decline in Subsequent Converters to Amnestic Pre-Mild Cognitive Impairment

ASYMMETRY OF MEDIAL TEMPORAL LOBE ASSOCIATED WITH COGNITIVE DETERIORATION IN SUBJECTIVE MEMORY DECLINE: A CHINESE COMMUNITY STUDY WITH ONE YEAR FOLLOW-UP

Asymmetric loss of parietal activity causes spatial bias in prodromal and mild Alzheimer's disease

P-024: the Pattern and Severity of FDG Pet Abnormalities in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer’s Disease Neuroimaging Initiative

A PET Study of Discrimination of Cerebral Glucose Metabolism in Alzheimer's Disease and Mild Cognitive Impairment